Related Experiment Video
Updated: Jul 30, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
[The hypothalamo-hypophyseal system in patients with multinodular colloid euthyroid goiter]
Summary
Thyrotropin-releasing hormone (TRH) tests reveal reduced pituitary TTH reserve in patients with multinodular euthyroid goiter, suggesting latent hyperthyroidism. This challenges the clinical euthyroid diagnosis in some patients.
Area of Science:
- Endocrinology
- Thyroidology
- Internal Medicine
Background:
- Multinodular colloid euthyroid goiter is a common thyroid condition.
- Accurate assessment of thyroid function is crucial for patient management.
- The thyrotropin-releasing hormone (TRH) test is a diagnostic tool for pituitary-thyroid axis evaluation.
Purpose of the Study:
- To investigate pituitary TTH reserve in patients with multinodular euthyroid goiter.
- To evaluate the utility of the TRH test in identifying subclinical thyroid dysfunction.
- To explore potential growth factor involvement in goiter pathogenesis.
Main Methods:
- Eighty patients with multinodular colloidal euthyroid goiter were assessed.
- The TRH stimulation test was performed on 22 patients and 7 healthy controls.
- Analysis of TSH (thyroid-stimulating hormone) and STH (somatotropic hormone) responses to TRH.
Main Results:
- A significant tendency towards reduced pituitary TTH reserve was observed in patients.
- TRH test results suggested latent hyperthyroidism in some patients, particularly those with Stage IV goiter.
- Three distinct STH reaction patterns were identified in response to TRH.
Conclusions:
- Clinical euthyroid diagnosis may be insufficient for patients with multinodular goiter.
- The TRH test can identify subclinical thyroid dysfunction, classifying some patients as having latent hyperthyroidism.
- Somatotropic hormone (STH) may play a role as a growth factor in the pathogenesis of multinodular colloid euthyroid goiter.
Related Concept Videos
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

